CH299530A - Process for the preparation of 4- (B-amino-γ-bromo-propyl) -imidazole-dihydrobromide. - Google Patents

Process for the preparation of 4- (B-amino-γ-bromo-propyl) -imidazole-dihydrobromide.

Info

Publication number
CH299530A
CH299530A CH299530DA CH299530A CH 299530 A CH299530 A CH 299530A CH 299530D A CH299530D A CH 299530DA CH 299530 A CH299530 A CH 299530A
Authority
CH
Switzerland
Prior art keywords
dihydrobromide
amino
imidazole
bromo
propyl
Prior art date
Application number
Other languages
German (de)
Inventor
F Hoffmann- Aktiengesellschaft
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH299530A publication Critical patent/CH299530A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

      Verfahren        zur        Herstellung    von     4#(ss=Amino-y-brom-propyl)-imidazol-dihydrobromid.       Es wurde gefunden, dass das     4-(ss-Amino-          y-brom-propyl)-imidazol-dihydrobromid    fol  gender     Strukturformel     
EMI0001.0008     
    eine starke protrahierte blutdrucksenkende       Wirkung        besitzt.    Diese     Eigenschaft    kommt  sowohl dem     Racemat    als auch beiden optischen  Antipoden zu.  



  Zur Herstellung des     4-(ss-Amino-y-brom-          propyl)        -imidazol-dihydrobromids    lässt man  Bromwasserstoff auf     ss    -     Amino    - y -     imidazolyl-          (4)-propanol    oder eines seiner Salze, gegebe  nenfalls in Gegenwart von Wasser oder Eis  essig,     einwirken.    Dadurch wird die     Hydroxyl-          gruppe    durch ein Bromatom ersetzt. Die ent  stehende Base bildet mit der überschüssigen  Säure das     Dihydrobromid,    welches als solches  isoliert wird.  



  Die neue Verbindung soll als Arzneimittel       Verwendung    finden.  



  Gegenstand des Patentes ist nun     ein    Ver  fahren zur Herstellung von     4-(ss-Amino-y-          brom-propyl)-imidazol-dihydrobromid,    das  dadurch gekennzeichnet ist, dass man Brom  wasserstoff auf     ss-Amino-y-imidazölyl-(4)-pro-          panol-dihydrobromid    einwirken lässt.

      Die neue Verbindung ist in Wasser und  Methanol leicht, in Äthanol schwerer     löslich     und in Äther     unlöslich;    die     D-Form    schmilzt  bei 210-212  unter Zersetzung, -die     L-Form     bei 210-212  unter Zersetzung und das     Race-          mat    bei 229-230  unter Zersetzung.  



  <I>Beispiel:</I>  1 Gewichtsteil     D-ss-Amino-y-imidazolyl-(4)-          propanol-dihydrobromid    wird mit 25 Gewichts  teilen einer gesättigten Lösung von     Bromwas-          serstoffsäure    in Eisessig im Bombenrohr vier  Stunden lang auf 105  geheizt. Nach dem  Erkalten wird die Lösung mit Wasserver  dünnt und zur Trockne eingeengt. Den festen  Rückstand löst man in Wasser und dampft  nach     Entfärbung    mit Kohle erneut zur       Trockne    ein.     Schliesslich    wird     nun    der Rück  stand in absolutem Methanol gelöst und durch  Zugabe von Äther zur     Kristallisation    gebracht.

    Das     D-4-(ss-Amino-y-brom-propyl)-imidazol-          dihydrobromid    wird     genutscht    und mit     Alko-          kol    und Äther gewaschen.     Ausbeute:    1 Ge  wichtsteil. Dieses Salz schmilzt unter Zer  setzung bei 210-212 .  
EMI0001.0051     




      Process for the preparation of 4 # (ss = amino-y-bromo-propyl) -imidazole-dihydrobromide. It was found that the 4- (ss-amino-y-bromo-propyl) -imidazole-dihydrobromide following gender structural formula
EMI0001.0008
    Has a strong protracted antihypertensive effect. This property applies to both the racemate and both optical antipodes.



  To prepare 4- (ß-amino-γ-bromopropyl) -imidazole dihydrobromide, hydrogen bromide is allowed to add to ß-amino-γ-imidazolyl- (4) propanol or one of its salts, if necessary in the presence of water or ice vinegar, act. This replaces the hydroxyl group with a bromine atom. The resulting base forms the dihydrobromide with the excess acid, which is isolated as such.



  The new compound is said to be used as a drug.



  The subject of the patent is now a process for the production of 4- (ss-amino-y-bromo-propyl) -imidazole-dihydrobromide, which is characterized in that hydrogen bromide is added to ss-amino-y-imidazölyl- (4) -pro- panol-dihydrobromide.

      The new compound is easily soluble in water and methanol, sparingly soluble in ethanol and insoluble in ether; the D-form melts at 210-212 with decomposition, the L-form at 210-212 with decomposition and the racemate at 229-230 with decomposition.



  <I> Example: </I> 1 part by weight of D-ss-amino-y-imidazolyl- (4) -propanol-dihydrobromide is heated to 105 for four hours with 25 parts by weight of a saturated solution of hydrobromic acid in glacial acetic acid in a sealed tube . After cooling, the solution is diluted with Wasserver and evaporated to dryness. The solid residue is dissolved in water and, after decolorization with charcoal, evaporated to dryness again. Finally, the residue is now dissolved in absolute methanol and crystallized by adding ether.

    The D-4- (ss-amino-y-bromo-propyl) -imidazole dihydrobromide is sucked off and washed with alcohol and ether. Yield: 1 part by weight. This salt melts with decomposition at 210-212.
EMI0001.0051


 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von 4-(ss-Amino- y-brom-propyl)-imidazol-dihydrobromid, da durch gekennzeichnet, dass man Bromwasser\ Stoff auf ss-Amino-y-imidazolyl-(4)-propanol- dihydrobr omid einwirken lässt. PATENT CLAIM Process for the production of 4- (ss-amino-y-bromo-propyl) -imidazole-dihydrobromide, characterized in that bromine water \ substance act on ss-amino-y-imidazolyl- (4) -propanol dihydrobromide leaves. Die neue Verbindung ist in Wasser und Methanol leicht, in Äthanol schwerer löslich und in Äther unlöslich; die D-Form schmilzt bei 210-212 unter Zersetzung, die L-Porm bei 210-212 unter Zersetzung und das Race- inat bei 229-230 unter Zersetzung. The new compound is easily soluble in water and methanol, sparingly soluble in ethanol and insoluble in ether; the D form melts at 210-212 with decomposition, the L-form at 210-212 with decomposition, and the racinate at 229-230 with decomposition.
CH299530D 1951-09-19 1951-09-19 Process for the preparation of 4- (B-amino-γ-bromo-propyl) -imidazole-dihydrobromide. CH299530A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH299530T 1951-09-19

Publications (1)

Publication Number Publication Date
CH299530A true CH299530A (en) 1954-06-15

Family

ID=4490346

Family Applications (1)

Application Number Title Priority Date Filing Date
CH299530D CH299530A (en) 1951-09-19 1951-09-19 Process for the preparation of 4- (B-amino-γ-bromo-propyl) -imidazole-dihydrobromide.

Country Status (1)

Country Link
CH (1) CH299530A (en)

Similar Documents

Publication Publication Date Title
DE1014551B (en) Process for the preparation of substituted 4-oxycoumarins
CH174811A (en) Process for the preparation of tropic acid-2,2-dimethyl-3-diethylaminopropanol ester.
DE1493626A1 (en) Process for the production of furan derivatives
CH299530A (en) Process for the preparation of 4- (B-amino-γ-bromo-propyl) -imidazole-dihydrobromide.
DE920250C (en) Process for the preparation of 4-(ª-amino-ª-bromopropyl)imidazole salts
DE2008332C3 (en) 2-methyl-S-methoxy-3-indolylacetohydroxamic acids, processes for their preparation and pharmaceuticals containing these compounds
DE2735052A1 (en) SQUARE BRACKET TO N-(2-DIPHENYLMETHOXYAETHYL)-N-(1-METHYL-2-PHENOXYAETHYL)-N-METHYL SQUARE BRACKET TO AMINE, ITS PRODUCTION AND USE IN PHARMACEUTICALS
CH304301A (en) Process for the preparation of 4- (B-amino-γ-bromopropyl) -imidazole-dihydrobromide.
DE1770250C2 (en) l-Cinnamoyl-3-indolylcarboxylic anhydrides, process for their preparation and medicinal preparations
AT227256B (en) Process for the production of new aminoindanes and their salts
AT147483B (en) Process for the preparation of compounds of methyl N-methyltetrahydronicotinate.
CH382181A (en) Process for the preparation of new substituted 3,3,3-triphenylpropylamines
AT234104B (en) Process for the production of new indolyl derivatives and their acid salts
DE663543C (en) Process for the production of Abkoemmlingen the pyrazine monocarboxylic acid
DE1670604C3 (en) 3-Mercapto-4,5-alkylene-1,2,4triazoles and process for their preparation
AT217162B (en) Process for the preparation of N-alkenyl-morphinans
AT227266B (en) Process for the preparation of new phenothiazine derivatives, as well as their acid addition salts and quaternary salts
CH373759A (en) Process for the production of a new heart-acting salt
CH300417A (en) Process for the preparation of a derivative of 3- (4&#39;-oxy-phenyl) -3- (4 &#34;-oxy-3&#34; -aminomethyl-phenyl) -oxindole.
CH303833A (en) Process for the preparation of derivatives of tetrahydro-γ-carboline.
CH548355A (en) 2-(6-Methoxy-2-naphthyl) propionic acid prepns. - anti-pyretics, analgesics, anti-inflammatory agents
CH242292A (en) Process for the preparation of a quaternary salt of the dimethylcarbamic acid ester of o-dimethylaminophenol.
CH284072A (en) Process for the preparation of 3,4-dimethyl-5-phenyl-2-imino-thiazolidine.
CH331982A (en) Process for making new esters
CH526546A (en) 3-phenyl-4-hydroxy-4-benzoylpiperidines - with hypolipaemic activity